My Profile
Rolfe Winkler
Your guide to
the capital jungle
See all posts
Sat 28 Nov 2009 | 8:28 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Curis, Inc.
Curis, Inc. (CRIS.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
CRIS
on other exchanges
As of 27 Nov 2009
2.54
USD
Price Change
-0.08
Percent Change
-3.05%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Noel, Mark
50
2008
Vice President - Technology Management and Intellectual Property
Qian, Changgeng
53
2006
Vice President - Discovery and Preclinical Research
Passeri, Daniel
48
2001
President, Chief Executive Officer, Director
Greenacre, Martyn
67
2000
Director
Tobin, James
64
2000
Director
Bayh, Susan
49
2000
Director
Davie, Joseph
69
2003
Director
Kaitin, Kenneth
56
2003
Director
Gray, Michael
38
2006
Chief Financial Officer, Chief Operating Officer
McNab, James
65
2002
Chairman of the Board
Find out more about CRIS.O
Insider Trading